Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07462247

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

The study is designed to collect magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, CT images, and histopathology results to establish a database for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Images of MCE for UGIC are scarce, limiting the development of corresponding AI diagnostic model. We aim to create an image database with MCE images, EGD images, CT images, and histopathology results, in patients treated by ESD for early upper gastrointestinal cancer, or biopsy for precancerous lesions, and precancerous conditions, so as to facilitate image-based deep learning studies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female participants aged ≥ 18 years
  • Patients with early upper gastrointestinal cancer referred for endoscopic submucosal dissection (ESD), or patients with upper gastrointestinal precancerous lesions or precancerous conditions referred for biopsy by esophagogastroduodenoscopy (EGD)
  • Participants who are willing and able to participate in this study, complete all required examinations and follow-up visits, and who have provided written informed consent

Exclusion criteria

  • Patients who are not eligible for surgery or who refuse any abdominal surgery in case of capsule retention and endoscopic retrieval failure
  • Patients with cardiac pacemaker or other implanted electromedical devices which could interfere with magnetic resonance
  • Suspected or known intestinal stenosis or other known risk factors for capsule retention
  • Patients with dysphagia
  • Pregnancy
  • Allergy to polymeric materials, latex, simethicone, or pronase
  • Patients plan to undergo magnetic resonance imaging examination before excretion of the capsule
  • Patients with any condition that precludes compliance with the study

Treatment and study plan

magnetically-controlled capsule endoscopy, esophagogastroduodenoscopy, CT scan

Diagnostic Test

Magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, and CT images for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions

ESD, biopsy

Procedure

ESD or biopsy for histopathology results

Primary outcomes

  1. Magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, and CT images

    Time frame: Prior to ESD or biopsy

  2. Histopathology results

    Time frame: During ESD or biopsy

Study contacts

Contact information is provided by the study sponsor or research team.

Jun Pan, MD

CONTACT

[email protected]

+86-13764598567

Sponsors and collaborators

Lead sponsor

Changhai Hospital

Other

Registry information

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Mar 10, 2026
Registry last updated
Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.